In summary, the present study demonstrated the effectiveness of the 5-HT7 antagonists SB-269970 and amisulpride in ameliorating ketamine-induced cognitive inflexibility, recognition memory impairment and social withdrawal. Here, HTR7 is linked to memory impairment.